Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Budesonide (oral use)

EU orphan designation number: EU/3/06/413   
Active ingredient: Budesonide (oral use)
Indication: Treatment of Graft-versus-Host disease
Sponsor: Dr. Falk Pharma GmbH
Leinenweberstrasse 5, D-79041 Freiburg, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/11/2006 Centralised Orphan - Designation EMEA/OD/049/06 (2006)5372 of 03/11/2006
22/12/2006 Corrigendum